Cassava Sciences, Inc. Share Price
NASDAQ: SAVA$0.00
+0.00 (0.00%) Cassava Sciences, Inc. Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
Cassava Sciences, Inc. Share Price Chart
$0.00$0.00
L
H
Cassava Sciences, Inc. Stock Fundamentals & Key Indicators
Market Cap N/A | PE Ratio (TTM) N/A | Dividend Yield N/A |
EPS (TTM) $-0.53 | Revenue (TTM) N/A | Return On Equity (TTM) -16.71% |
Profit Margin N/A | Debt to Equity 0.08 | Quarterly Earnings Growth YoY 61.32% |
Cassava Sciences, Inc. Quarterly Profit & Loss
All figures in USD
Cassava Sciences, Inc. Annual Profit & Loss
All figures in USD
About Cassava Sciences, Inc.
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. Cassava Sciences, Inc. was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.
Cassava Sciences, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|
SAVA Share Price FAQs
What is Cassava Sciences, Inc. share price today?
Cassava Sciences, Inc. share price today is $0.00 as on August 10, 2026 at 12:08 pm IST.
What is the 52 week high and 52 week low of Cassava Sciences, Inc. stock?
52 week high/low data for Cassava Sciences, Inc. is currently unavailable.
What is SAVA's net income for the last quarter?
SAVA's net income for the last quarter is -0.01B USD.
Can I buy SAVA shares in India?
Yes. You can buy SAVA in India by opening an international trading account.